CHU Purpan

Academic/Hospital

Also known as: CHU Purpan (Toulouse) | CHU Purpan - Toulouse (France) | Clinique Neurologique CHU Purpan Toulouse 31059 France; demonet@toulouse.inserm.fr

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Sep 1, 2005

Last known activity

Jun 1, 2013

Timeline

No events for the selected filters.

Drugs by trial phase (3 distinct, 3 trials)

Phase 4 (1 own, 0 via acquisition)

rasagiline

Phase 2 (2 own, 0 via acquisition)

maraviroc
memantine

Indications

Studied for

Acquired Immunodeficiency Syndrome
Aphasia, Primary Progressive
Communicable Diseases
Dementia
Frontotemporal Dementia
HIV Infections
Infections
Parkinson Disease
Pick Disease of the Brain

Recent trials (3)

NCT01765257CollaboratorPhase 4Jun 1, 2013
NCT00944541Overall official - principal investigatorPhase 2Sep 1, 2009
NCT00200538Overall official - principal investigatorPhase 2Sep 1, 2005

Details

Last known activity: Jun 1, 2013